IMMUNITYBIO, INC. Unrealized Gain (Loss) on Investments
IMMUNITYBIO, INC. (IBRX) reported Unrealized Gain (Loss) on Investments of -$336.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-04
- IMMUNITYBIO, INC. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was -$156.00K.
- IMMUNITYBIO, INC. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$180.00K.
- IMMUNITYBIO, INC. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $43.00K, a 12.24% decline year-over-year.
- IMMUNITYBIO, INC. unrealized gain (loss) on investments for the quarter ending 2025-06-30 was -$4.00K, a 180.00% decline year-over-year.
- IMMUNITYBIO, INC. unrealized gain (loss) on investments for fiscal 2022 was -$59.00K.
- IMMUNITYBIO, INC. unrealized gain (loss) on investments for fiscal 2021 was -$13.00K.
- IMMUNITYBIO, INC. unrealized gain (loss) on investments for fiscal 2020 was -$17.00K, a 106.59% decline from fiscal 2019.
- IMMUNITYBIO, INC. unrealized gain (loss) on investments for fiscal 2019 was $258.00K, a 109.76% increase from fiscal 2018.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 3 month as first filed | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$156.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$336.00K 10-Q · filed 2026-08-04 | ||||
| 2026-03-31 | -$180.00K 10-Q · filed 2026-05-07 | |||||
| 2025-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $39.00K derived: sum of 2 quarters · filed 2026-08-04 | $28.00K 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$15.00K 10-Q · filed 2026-08-04 | ||||
| 2025-03-31 | -$11.00K 10-Q · filed 2026-05-07 | |||||
| 2024-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $54.00K derived: sum of 2 quarters · filed 2025-11-05 | $86.00K 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $37.00K 10-Q · filed 2025-08-05 | ||||
| 2024-03-31 | $32.00K 10-Q · filed 2025-05-12 | |||||
| 2023-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $24.00K derived: sum of 2 quarters · filed 2024-11-12 | $34.00K 10-Q · filed 2024-11-12 | $39.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $4.00K 10-Q · filed 2024-08-12 | $9.00K derived: sum of 3 quarters · filed 2024-08-12 | -$13.00K derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-09 | $15.00K derived: sum of 2 quarters · filed 2024-05-09 | -$7.00K derived: sum of 3 quarters · filed 2024-05-09 | $261.00K derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$17.00K derived: sum of 2 quarters · filed 2023-11-09 | $251.00K derived: sum of 3 quarters · filed 2023-11-09 | -$59.00K 10-K · filed 2023-03-01 | ||
| 2022-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $246.00K derived: sum of 2 quarters · filed 2023-11-09 | -$64.00K 10-Q · filed 2023-11-09 | -$93.00K derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $268.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$42.00K 10-Q · filed 2023-08-08 | -$71.00K derived: sum of 3 quarters · filed 2023-08-08 | -$72.00K derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | -$310.00K 10-Q · filed 2023-05-11 | -$339.00K derived: sum of 2 quarters · filed 2023-05-11 | -$340.00K derived: sum of 3 quarters · filed 2023-05-11 | -$337.00K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$30.00K derived: sum of 2 quarters · filed 2023-03-01 | -$27.00K derived: sum of 3 quarters · filed 2023-03-01 | -$13.00K 10-K · filed 2023-03-01 | ||
| 2021-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.00K derived: sum of 2 quarters · filed 2022-11-09 | $16.00K 10-Q · filed 2022-11-09 | $11.00K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $17.00K 10-Q · filed 2022-08-08 | $12.00K derived: sum of 3 quarters · filed 2023-03-01 | -$5.00K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $14.00K 10-Q · filed 2022-05-10 | $9.00K derived: sum of 2 quarters · filed 2023-03-01 | -$8.00K derived: sum of 3 quarters · filed 2023-03-01 | -$26.00K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$22.00K derived: sum of 2 quarters · filed 2023-03-01 | -$40.00K derived: sum of 3 quarters · filed 2023-03-01 | -$17.00K 10-K · filed 2023-03-01 | ||
| 2020-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$35.00K derived: sum of 2 quarters · filed 2021-11-12 | -$12.00K 10-Q · filed 2021-11-12 | -$25.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $5.00K 10-Q · filed 2021-08-12 | -$8.00K derived: sum of 3 quarters · filed 2022-03-01 | $23.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $23.00K 10-Q · filed 2021-05-14 | -$23.00K 10-Q · filed 2020-05-11 | $10.00K derived: sum of 2 quarters · filed 2022-03-01 | $41.00K derived: sum of 3 quarters · filed 2022-03-01 | $163.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $18.00K derived: sum of 2 quarters · filed 2022-03-01 | $140.00K derived: sum of 3 quarters · filed 2022-03-01 | $258.00K 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $153.00K derived: sum of 2 quarters · filed 2020-11-09 | $271.00K 10-Q · filed 2020-11-09 | $361.00K derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-06-30 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $240.00K 10-Q · filed 2020-08-07 | $330.00K derived: sum of 3 quarters · filed 2021-03-04 | $430.00K derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-03-31 | $118.00K 10-Q · filed 2020-05-11 | $208.00K derived: sum of 2 quarters · filed 2021-03-04 | $308.00K derived: sum of 3 quarters · filed 2021-03-04 | $415.00K derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2018-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $190.00K derived: sum of 2 quarters · filed 2021-03-04 | $297.00K derived: sum of 3 quarters · filed 2021-03-04 | $123.00K 10-K · filed 2021-03-04 | ||
| 2018-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $207.00K derived: sum of 2 quarters · filed 2019-11-05 | $33.00K 10-Q · filed 2019-11-05 | -$172.00K derived: sum of 4 quarters · filed 2020-03-25 | ||
| 2018-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$67.00K 10-Q · filed 2019-08-06 | -$272.00K derived: sum of 3 quarters · filed 2020-03-25 | -$238.00K derived: sum of 4 quarters · filed 2020-03-25 | ||
| 2018-03-31 | -$174.00K 10-Q · filed 2019-05-08 | -$379.00K derived: sum of 2 quarters · filed 2020-03-25 | -$345.00K derived: sum of 3 quarters · filed 2020-03-25 | -$341.00K derived: sum of 4 quarters · filed 2020-03-25 | ||
| 2017-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$171.00K derived: sum of 2 quarters · filed 2020-03-25 | -$167.00K derived: sum of 3 quarters · filed 2020-03-25 | -$97.00K 10-K · filed 2020-03-25 | ||
| 2017-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $38.00K derived: sum of 2 quarters · filed 2018-11-07 | $108.00K 10-Q · filed 2018-11-07 | -$500.00K derived: sum of 4 quarters · filed 2019-03-13 | ||
| 2017-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $74.00K 10-Q · filed 2018-08-06 | -$534.00K derived: sum of 3 quarters · filed 2019-03-13 | -$990.00K derived: sum of 4 quarters · filed 2019-03-13 | ||
| 2017-03-31 | $70.00K 10-Q · filed 2018-05-07 | -$538.00K derived: sum of 2 quarters · filed 2019-03-13 | -$994.00K derived: sum of 3 quarters · filed 2019-03-13 | -$828.00K derived: sum of 4 quarters · filed 2019-03-13 | ||
| 2016-12-31 | -$608.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$1.06M derived: sum of 2 quarters · filed 2019-03-13 | -$898.00K derived: sum of 3 quarters · filed 2019-03-13 | -$102.00K 10-K · filed 2019-03-13 | ||
| 2016-09-30 | -$456.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$290.00K derived: sum of 2 quarters · filed 2017-11-07 | $506.00K 10-Q · filed 2017-11-07 | $324.00K derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $962.00K 10-Q · filed 2017-08-07 | $780.00K derived: sum of 3 quarters · filed 2018-03-12 | |||
| 2016-03-31 | $796.00K 10-Q · filed 2017-05-08 | $614.00K derived: sum of 2 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | -$182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$182.00K 10-K · filed 2018-03-12 | $182.00K 10-K · filed 2016-03-30 | |||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 | |||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |